Normalization of abnormal plasma amino acid profile-based indexes in patients with gynecological malignant tumors after curative treatment.

Yukio SuzukiAya Tokinaga-UchiyamaTaichi MizushimaYasuyo MaruyamaTae MogamiNahoko ShikataAtsuko IkedaHiroshi YamamotoEtsuko Miyagi

Published in: BMC cancer (2018)

The API is a promising tumor marker in gynecological malignancies for the diagnosis of remission, particularly in patients negative for general tumor markers. Further studies are needed to explore the mechanisms related to the normalization of abnormal amino acid profiles.

Keyphrases

amino acid
end stage renal disease
prognostic factors
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
patient reported outcomes
rectal cancer
case control
replacement therapy